Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Somnomed Limited ( (AU:SOM) ) has provided an announcement.
Somnomed Limited has announced a change in the director’s interest, specifically regarding Michael Gordon, who has acquired 200,000 additional options, increasing his total to 885,000 options. This change was approved at the company’s Annual General Meeting and reflects a strategic move to align the director’s interests with the company’s growth objectives, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on providing innovative solutions for sleep-related disorders. The company is known for its oral appliance therapy products, which are designed to treat obstructive sleep apnea and other sleep-related conditions.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
See more data about SOM stock on TipRanks’ Stock Analysis page.